Selection of antigen receptors in splenic marginal-zone lymphoma: Further support from the analysis of the immunoglobulin light-chain gene repertoire

Leukemia

Volumn 26, Issue 12, 2012, Pages 2567-2569

  Bikos, V ^a   Stalika, E ^a,b   Baliakas, P ^b   Darzentas, N ^a,c   Davis, Z ^d   Traverse Glehen, A ^e   Dagklis, A ^f   Kanellis, G ^g   Anagnostopoulos, A ^b   Tsaftaris, A ^a   Ponzoni, M ^h   Berger, F ^e   Felman, P ^e   Ghia, P ^f   Papadaki, T ^g   Oscier, D ^d   Belessi, C ⁱ   Stamatopoulos, K ^a,b  

^a INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c MASARYK UNIVERSITY   (Czech Republic)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^e UNIVERSITÉ LYON 1   (France)

^f Laboratory of B Cell Neoplasia and Lymphoma Unit   (Italy)

^g EVANGELISMOS HOSPITAL   (Greece)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ GENERAL HOSPITAL OF NIKEA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; GLUTAMIC ACID; IMMUNOGLOBULIN LIGHT CHAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; GENE REARRANGEMENT; HUMAN; LETTER; PRIORITY JOURNAL; SPLEEN; SPLENIC MARGINAL ZONE LYMPHOMA;

GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENES, IMMUNOGLOBULIN LIGHT CHAIN; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; PROGNOSIS; SPLENIC NEOPLASMS;

EID: 84871209150     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.207     Document Type: Letter

References (15)

1. Bikos V, Darzentas N, Hadzidimitriou A, Davis Z, Hockley S, Traverse-Glehen A et al. Over 30% of patients with splenic marginal zone lymphoma express the same immuno-globulin heavy variable gene: ontogenetic implications. Leukemia 2012; 26: 1638-1646.
2. Lamminmaki U, Kankare JA. Crystal structure of a recombinant anti-estradiol Fab fragment in complex with 17beta-estradiol. J Biol Chem 2001; 276: 36687-36694.
3. Suzuki N, Harada T, Mihara S, Sakane T. Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoanti-body in patients with systemic lupus erythematosus. J Clin Invest 1996; 98: 1843-1850.
4. Lee J, Cho YJ, Lipsky PE. The V(lambda)-J(lambda) repertoire of patients with systemic lupus erythematosus manifests characteristics of the natural antibody repertoire. Arthritis Rheum 2004; 50: 2604-2614.
5. McIntosh RS, Asghar MS, Watson PF, Kemp EH, Weetman AP. Cloning and analysis of IgG kappa and IgG lambda anti-thyroglobulin autoantibodies from a patient with Hashimoto's thyroiditis: evidence for in vivo antigen-driven repertoire selection. J Immunol 1996; 157: 927-935.
6. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006; 6: 728-740.
7. Li H, Jiang Y, Prak EL, Radic M, Weigert M. Editors and editing of anti-DNA receptors. Immunity 2001; 15: 947-957.
8. Hadzidimitriou A, Darzentas N, Murray F, Smilevska T, Arvaniti E, Tresoldi C et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 2009; 113: 403-411.
9. Stamatopoulos K, Belessi C, Papadaki T, Kalagiakou E, Stavroyianni N, Douka V et al. Immunoglobulin heavy-and light-chain repertoire in splenic marginal zone lymphoma. Mol Med 2004; 10: 89-95.
10. Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, Baseggio L et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 2005; 90: 470-478.
11. Swerdlow S, Campo E, Harris NL et al. (eds). WHO Classification of Tumors of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008.
12. Zibellini S, Capello D, Forconi F, Marcatili P, Rossi D, Rattotti S et al. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 2010; 95: 1792-1796.
13. Warsame AA, Aasheim HC, Nustad K, Troen G, Tierens A, Wang V et al. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly-and self-reactive antibodies with similar reactivity. Blood 2011; 118: 3331-3339.
14. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005; 26: 347-362.
15. Weill JC, Weller S, Reynaud CA. Human marginal zone B cells. Annu Rev Immunol 2009; 27: 267-285.